NANO-X Imaging Announced That Nanox.AI's HealthCCSng AI Solution Reveals ~60% Of Patients In Study Had Previously Undetected Risk Of A Cardiovascular Event From Routine Chest CTs
Portfolio Pulse from Benzinga Newsdesk
Nanox.AI, a subsidiary of NANO-X Imaging, has revealed that its HealthCCSng AI solution identified a previously undetected risk of a cardiovascular event in approximately 60% of patients in a study. The study, conducted by Beilinson Hospital in Israel, used routine chest CT scans to assess the impact of AI-based coronary artery calcium (CAC) measurements. The majority of patients needed further evaluation and treatment.
September 28, 2023 | 12:35 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The successful application of Nanox.AI's HealthCCSng AI solution in identifying cardiovascular risks could potentially boost the reputation and demand for NANO-X Imaging's products.
The successful application of Nanox.AI's AI solution in a study conducted by Beilinson Hospital in Israel could potentially increase the demand for NANO-X Imaging's products. This is because the AI solution was able to identify previously undetected cardiovascular risks in patients, which is a significant achievement in the medical field. This could lead to increased sales and revenue for NANO-X Imaging, thereby potentially boosting its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100